PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
05-Mar-2025 NewBiologix Announces White Paper on Improving the Manufacturing of Recombinant Adeno-Associated Viruses for Use in Cell & Gene Therapies NewBiologix
05-Mar-2025 Bioxodes obtains Orphan Drug Designation for hemorrhagic stroke therapeutic candidate in US and Europe Bioxodes SA
05-Mar-2025 ABPI welcomes new MHRA Chief Executive Officer ABPI
04-Mar-2025 OncoZenge AB receives positive assessment regarding the PCT-patent application for BupiZenge™ OncoZenge AB
04-Mar-2025 Carbon Minimal pressurised Metered Dose Inhalers (pMDIs) could save up to 619,000 tonnes of emissions each year,[i] representing up to 7%-10% of NHS Net Zero targets[ii] The Office of Health Economics (OHE)
04-Mar-2025 FibroBiologics Files Patent For Novel Approach to Modulate Mitochondrial Activity Using Fibroblast-based Therapeutics FibroBiologics
04-Mar-2025 AC Immune to Participate in Upcoming Investor Conferences AC Immune
04-Mar-2025 Stryker launches Sync Badge Stryker
04-Mar-2025 AbbVie and Gubra Announce License Agreement to Develop an Amylin Analog for the Treatment of Obesity AbbVie
04-Mar-2025 Depemokimab applications accepted for review by the US FDA for asthma with type 2 inflammation and for chronic rhinosinusitis with nasal polyps (CRSwNP) GSK
04-Mar-2025 Imfinzi-based perioperative regimen recommended for approval in the EU by CHMP for resectable non-small cell lung cancer AstraZeneca
04-Mar-2025 Eisai Receives Regulatory Review Outcome for Lecanemab as a Treatment for Early Alzheimer’s Disease in Australia Eisai
04-Mar-2025 LinkGevity Awarded Innovate UK Smart Grant for Anti-Necrotic TM Research to Prevent Kidney Deterioration LinkGevity
04-Mar-2025 Allegro reports positive safety data for its injectable osteoarthritis treatment in three preclinical studies Allegro
04-Mar-2025 Sofinnova Partners raises €1.2 billion to fuel the next wave of life sciences innovation Sofinnova Partners
04-Mar-2025 ONWARD Medical to Advance Parkinson’s Disease Pipeline with Support from The Michael J. Fox Foundation and US Department of Defense ONWARD Medical
04-Mar-2025 Delivering the NHS 10-Year Plan will require a fourth ‘shift’ says ABPI ABPI
04-Mar-2025 Preliminary figures for Medios AG 2024: Significant increase in earnings and margins – positive outlook for 2025 Medios AG
04-Mar-2025 Evotec Announces Key Progress in Neuroscience Collaboration with Bristol Myers Squibb Evotec SE
04-Mar-2025 AEVIS VICTORIA SA – Strong growth in 2024 revenue and improved profitability AEVIS VICTORIA SA